Highest development stage: Preclinical

Development status: Inactive

Gram-positive activity

Mechanism of Action/Target pathogen: Active against Gram-positive bacteria, identical to Josamycin

Additional information: Higashide, E et al "Maridomycin, a New Macrolide Antibiotic" Program and Abstracts of the interscience science Conference on Antimicrobial Agents and Chemotherapy. 1971.